Biodesign Institute's Josh LaBaer describes how his lab scaled up in a time of intense supply challenges
Electronic health records have been widely adopted with the hope they would save time and improve the quality of patient care. But due to fragmented interfaces and tedious data entry procedures, physicians often spend more time navigating these systems than they do interacting with patients.
So-called tumor suppressor genes have long been known to block cell growth, preventing cancerous cells from spreading. Mutations in these genes, scientists believed, thus allow tumors to flourish unchecked.
Extremely premature infants are at a high risk for brain damage.
Key TakeawaysA new economic and health model estimates that cases of cardiovascular disease and diabetes in the US would drop substantially if the food industry reformulates sugary products in 15 food categories.By quantifying the healthcare and societal cost savings of Americans reducing their sugar consumption, the model may spur the launch of a national sugar-reduction policy aimed at food manufacturers.Cutting 20% of sugar from packaged foods and 40% from beverages could prevent 2.48 million cardiovascular disease events (such as strokes, heart attacks, cardiac arrests), 490,000 cardiovascular deaths, and 750,000 diabetes cases in the U.S.
Anxiety, addiction, and other psychiatric disorders are often characterized by intense states of what scientists call arousal: The heart races, blood pressure readings rise, breaths shorten, and “bad” decisions are made.
A team of researchers at Cornell University has found that the common antipsychotic drug thioridazine suppresses the tumor activity of many malignant testicular germ cell tumors in laboratory mice.
Prosthetic enables a wide range of daily activities, such as zipping a suitcase, shaking hands, and petting a cat.
Centenarians are less susceptible to age-related chronic diseases and more likely to survive infectious diseases.
Most studies of genetic risks for type 2 diabetes have focused only on people of European ancestry, although the prevalence of the disease is rising more rapidly in other populations.
Chronic osteomyelitis, a progressive infection in bone, can occur after treatment for acute osteomyelitis, a new infection in bone that usually results from injury.
Scientists at Yale School of Medicine are participating in an unprecedented and comprehensive study of the effects of COVID-19 on patients.
A team led by researchers at Baylor College of Medicine found that a screening method known as untargeted metabolomics profiling can improve the diagnostic rate for inborn errors of metabolism, a group of rare genetic conditions, by about seven-fold when compared to the traditional metabolic screening approach.
A group of Italian medical researchers has issued a "call for action" to the medical community to protect frontline healthcare workers from heavy psychological stress in dealing with COVID-19 patients.
A snapshot of the results of Israel's national vaccination campaign indicates that the Pfizer-BioNTech vaccine has dramatically reduced the number of cases of COVID-19, the number of hospitalizations and the number of critically ill patients.
Researchers have found a way to alter human calcitonin into a safe and effective drug for the treatment of osteoporosis and other bone diseases.
University of California Los Angeles (UCLA) has forged a new partnership with a South Korean pharmaceutical company to develop a new multiple sclerosis treatment, according to a press release.
A clinical trial of a drug that targets the interleukin 17 family of cytokines could lead to a preventive treatment for acute respiratory distress syndrome (ARDS) in COVID-19.
A research team from the Weizmann Institute of Science in Israel reviews the different types of antibody tests for COVID-19, and their importance, in a January 2021 preprint of Cell Reports Medicine.
Injecting patients with a gel that would dissolve over several months could replace the need to administer daily or weekly shots. But to make this possible, researchers first had to create a Jello-like substance that could defy one of the fundamental laws of nature.